| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af5978c465dc99fa57524ae217ad798f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3756
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372 |
| filingDate |
2022-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cdd86c9aabf494f7f88192a4b0e78b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8248e4fdac538babccf8a5af294baa32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff61b0669baacd302d454380d5332247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fe16613be1406c556590098bf48fd91 |
| publicationDate |
2022-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022272164-A1 |
| titleOfInvention |
Bioresorbable cardiovascular instruments, and operation and fabrication methods of same |
| abstract |
A device implantable on a target of interest of a subject for pacemaker, neuromodulator, and/or defibrillator therapy comprises a wireless power harvesting unit configured to deliver power via resonant inductive coupling to the target tissue for stimulation in a manner that eliminates need for batteries and allows for externalized control without transcutaneous leads. The device relies exclusively on materials that resorb when exposed to biofluids in a time-controlled manner via metabolic action and hydrolysis. The materials and design choices create a thin, flexible, and lightweight form that maintain excellent biocompatibility and stable function throughout a desired period of use. Over a subsequent timeframe following the completion of therapy, the devices disappear completely through natural biological processes. These characteristics and a miniaturized geometry facilitate full implantation into the body to eliminate the need for percutaneous hardware, which thereby minimizes the risk of device-associated infections and dislodgement. |
| priorityDate |
2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |